DECISION ADOPTED BY THE PARTIES TO THE CARTAGENA PROTOCOL ON BIOSAFETY CP-10/10. Risk assessment and risk management (Articles 15 and 16) CP-10/10. Dec 2022. Montreal, Canada. PDF

DECISION ADOPTED BY THE PARTIES TO THE CARTAGENA PROTOCOL ON BIOSAFETY 9/13. Risk assessment and risk management (Articles 15 and 16). CBD/CP/MOP/DEC/9/13 30 November 2018. PDF

CONSIDERATIONS ON RISK ASSESSMENT AS PER DECISION CP-9/13. CBD/CP/RA/AHTEG/2020/1/2 15 March 2020. PDF

STUDY ON RISK ASSESSMENT: APPLICATION OF ANNEX I OF DECISION CP-9/13 TO LIVING MODIFIED ORGANISMS CONTAINING ENGINEERED GENE DRIVES. CBD/CP/RA/AHTEG/2020/1/4 21 February 2020. PDF

  • Contains the Study on Risk Assessment Application of annex I of decision CP 9/13 to living modified organisms containing engineered gene drives. February 2020 Authors: G. Smets & P. Rüdelsheim. On behalf of the Secretariat of the Convention on Biological Diversity
  • Contains the Study on Risk Assessment Application of annex I of decision CP 9/13 to living modified organisms containing engineered gene drives. February 2020 Authors: G. Smets & P. Rüdelsheim. On behalf of the Secretariat of the Convention on Biological Diversity

Decision adopted by the Conference of the Parties to the Convention on Biological Diversity serving as the meeting of the Parties to the Cartagena Protocol on Biosafety on 1 November 2024 CBD/CP/MOP/DEC/11/4. 1 November 2024. PDF

Additional voluntary guidance materials to support case-by-case risk assessments of living modified organisms containing engineered gene drives. CBD/CP/MOP/11/9. PDF

Secretariat of the Convention on Biological Diversity (2015). Synthetic biology- Part I: Potential Impacts of Synthetic Biology on Biological Diversity Part II: Gaps and Overlaps with the Provisions of the Convention and Other Agreements, Montreal, Technical Series No. 82, 118 pages. PDF